Bilberry/evening primrose/flax Drug Interactions
Currently displaying a list of 261 drugs known to interact with bilberry / evening primrose / flax.
- 1 major drug interaction
- 1 moderate drug interaction
- 259 minor drug interactions
Medications known to interact with bilberry/evening primrose/flax
Note: Showing generic names only.
A
- abciximab
- acetazolamide
- aldesleukin
- alfentanil
- amantadine
- amifampridine
- aminophylline
- amitriptyline
- amoxapine
- amphetamine
- anagrelide
- anisindione
- antithrombin (recombinant)
- antithrombin iii
- apalutamide
- apixaban
- ardeparin
- argatroban
- aripiprazole
- asenapine
- aspirin
B
- benzgalantamine
- benzphetamine
- bethanechol
- betrixaban
- bivalirudin
- blinatumomab
- brexpiprazole
- brivaracetam
- buprenorphine
- bupropion
- butorphanol
C
- C1 esterase inhibitor (human)
- cangrelor
- cannabidiol
- caplacizumab
- carbamazepine
- cariprazine
- cefiderocol
- cenobamate
- chloroquine
- chlorpromazine
- cilostazol
- cinoxacin
- ciprofloxacin
- citalopram
- clobazam
- clomipramine
- clonazepam
- clopidogrel
- clozapine
- cocaine nasal
- codeine
- cyclobenzaprine
- cycloserine
D
- dabigatran
- dalfampridine
- dalteparin
- danaparoid
- defibrotide
- delafloxacin
- desipramine
- desirudin
- desvenlafaxine
- dexfenfluramine
- dexmethylphenidate
- dextroamphetamine
- dezocine
- diazepam
- dicumarol
- diethylpropion
- dipyridamole
- divalproex sodium
- donepezil
- doxapram
- doxepin
- doxepin topical
- dronabinol
- drotrecogin alfa
- duloxetine
E
- edoxaban
- enoxacin
- enoxaparin
- enzalutamide
- ephedrine
- eptifibatide
- ertapenem
- escitalopram
- eslicarbazepine
- ethosuximide
- ethotoin
- ezetimibe
- ezogabine
F
- fedratinib
- felbamate
- fenfluramine
- fentanyl
- fluoxetine
- fluphenazine
- fluvoxamine
- fondaparinux
- foscarnet
- fosphenytoin
G
H
I
- ibrutinib
- iloperidone
- imipramine
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfa-n3
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- interferon gamma-1b
- isocarboxazid
L
- lacosamide
- lamotrigine
- lepirudin
- levetiracetam
- levofloxacin
- levomethadyl acetate
- levomilnacipran
- levorphanol
- lidocaine
- lindane topical
- lisdexamfetamine
- lithium
- lomefloxacin
- lorazepam
- loxapine
- lumateperone
- lurasidone
M
- ma huang
- maprotiline
- mazindol
- mefloquine
- meperidine
- mephenytoin
- mephobarbital
- meropenem
- mesoridazine
- methadone
- methamphetamine
- methdilazine
- methotrimeprazine
- methsuximide
- methylphenidate
- metoclopramide
- mexiletine
- milnacipran
- mirtazapine
- molindone
- morphine
- morphine liposomal
- moxifloxacin
- muromonab-cd3
N
O
- ofloxacin
- olanzapine
- oliceridine
- opium
- oxamniquine
- oxcarbazepine
- oxtriphylline
- oxycodone
- oxymorphone
P
- paliperidone
- paraldehyde
- paramethadione
- paroxetine
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- pemoline
- pentazocine
- perampanel
- perphenazine
- phenacemide
- phendimetrazine
- phenelzine
- phenobarbital
- phensuximide
- phentermine
- phenylpropanolamine
- phenytoin
- physostigmine
- pimozide
- piperazine
- prasugrel
- pregabalin
- primidone
- prochlorperazine
- promazine
- promethazine
- propiomazine
- propoxyphene
- protein c
- protriptyline
- pseudoephedrine
Q
R
S
T
- tacrine
- tapentadol
- theophylline
- thiethylperazine
- thioridazine
- thiothixene
- tiagabine
- ticagrelor
- ticlopidine
- tinzaparin
- tirofiban
- topiramate
- tramadol
- tranylcypromine
- trazodone
- trifluoperazine
- triflupromazine
- trimeprazine
- trimethadione
- trimipramine
- trovafloxacin
V
W
Z
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.